Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 1

Status

Completed 5Terminated 3Unknown 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Lung Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Adenocarcinoma 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Interventional × tetrathiomolybdate × Clear all
NCT01837329 2019-07-19

Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung Cancer

University of Rochester

Phase 1 Completed
26 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00176800 2016-08-22

Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma

University of Michigan Rogel Cancer Center

Phase 2 Completed
69 enrolled 7 charts
Gastrointestinal

Esophageal Neoplasms

NCT00150995 2015-01-21

Tetrathiomolybdate in Hormone Refractory Prostate Cancer

University of Michigan Rogel Cancer Center

Phase 2 Completed
19 enrolled
Genitourinary

Prostatic Neoplasms

NCT00176774 2012-02-07

Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma

University of Michigan Rogel Cancer Center

Phase 2 Completed
24 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00006332 2005-06-24

Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate

National Center for Research Resources (NCRR)

Phase 2 Completed
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡